mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Chiaki Kawase et al.|Clinical Cancer Research|2009Cited by 155
Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the OvaryTakeshi Hisamatsu, Tadashi Kimura, Tomoyuki Sasano et al.|Molecular Cancer Therapeutics|2013Cited by 41